Risk of colonic cancer is not higher in the obese Lepob mouse model compared to lean littermates

Pathology and Oncology Research

Volumn 19, Issue 4, 2013, Pages 867-874

  Sikalidis, Angelos K ^a,b   Fitch, Mark D ^a   Fleming, Sharon E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Aberrant crypts; Azoxymethane; Leptin; Proliferation; Tumors

Indexed keywords

AZOXYMETHANE; CARCINOGEN; LEPTIN;

ABERRANT CRYPT FOCUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RISK; CARCINOGENESIS; CELL PROLIFERATION; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; IN VIVO STUDY; LEAN BODY WEIGHT; MALE; MOUSE; NONHUMAN; OBESITY; RISK ASSESSMENT;

ABERRANT CRYPT FOCI; ANALYSIS OF VARIANCE; ANIMALS; AZOXYMETHANE; COLONIC NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; RANDOM ALLOCATION;

EID: 84885183837     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-013-9656-7     Document Type: Article

References (52)

1. Caan BJ, Coates AO, Slattery ML, Potter JD, Quesenberry CP Jr, Edwards SM (1998) Body size and the risk of colon cancer in a large case-control study. Int J Obes Relat Metab Disord 22(2):178-184
2. Boyle T, Keegel T, Bull F, Heyworth J, Fritschi L (2012) Physical activity and risks of proximal and distal colon cancers: a systematic review and meta-analysis. J Natl Cancer Inst 104(20):1548-1561
3. Kono S, Handa K, Hayabuchi H, Kiyohara C, Inoue H et al (1999) Obesity, weight gain and risk of colon adenomas in Japanese men. Jpn J Cancer Res 90(8):805-811
4. Suh S, Kang M, Kim MY, Chung HS, Kim SK et al (2011) Korean type 2 diabetes patients have multiple adenomatous polyps compared to non-diabetic controls. J Korean Med Sci 26(9):1196-1200
5. Wolin KY, Yan Y, Colditz GA (2011) Physical activity and risk of colon adenoma: a meta-analysis. Br J Cancer 104(5):882-885
6. Ma Y, Yang Y, Wang F, Zhang P, Shi C et al (2013) Obesity and risk of colorectal cancer: a systematic review of prospective studies. PLoS One 8(1):e53916
7. Maruthur NM, Bolen S, Gudzune K, Brancati FL, Clark JM (2012) Body mass index and colon cancer screening: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 21(5):737-746
8. Ford ES (1999) Body mass index and colon cancer in a national sample of adult US men and women. Am J Epidemiol 150(4):390-398
9. Murphy TK, Calle EE, Rodriguez C, Khan HS, Thun MJ (2000) Body mass index and colon cancer mortality in a large prospective study. Am J Epidemiol 152(9):847-854
10. Gerhardsson de Verdier M, Hagman U, Steineck G, Rieger A, Norell SE (1990) Diet, body mass and colorectal cancer: a case-referent study in Stockholm. Int J Cancer 46(5):832-838
11. Bostick RM, Potter JD, Kushi LH, Sellers TA, Steinmetz KA et al (1994) Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Control 5(1):38-52
12. Yu XF, Wang YQ, Zou J, Dong J (2012) A meta-analysis of the effects of energy intake on risk of digestive cancers. World J Gastreneterol 18(48):7362-7370
13. Bergstrom A, Pisani P, Tenet V, Wolk A, Adami HO (2001) Overweight as an avoidable cause of cancer in Europe. Int J Cancer 91(3):421-430
14. Tashiro M, Akiyama T, Yoshikawa I, Kume K, Otsuki M (2004) Obesity as a risk factor for colorectal polyps in Japanese patients. Gut 53(1):156
15. Lee WM, Lu S, Medline A, Archer MC (2001) Susceptibility of lean and obese Zucker rats to tumorigenesis induced by N-methyl-N-nitrosourea. Cancer Lett 162(2):155-160
16. Hakkak R, Holley AW, Macleod SL, Simpson PM, Fuchs GJ et al (2005) Obesity promotes 7,12-dimethylbenz(a)anthracene-induced mammary tumor development in female zucker rats. Breast Cancer Res 7(5):R627-R633
17. Weber RV, Stein DE, Scholes J, Kral JG (2000) Obesity potentiates AOM-induced colon cancer. Dig Dis Sci 45(45):890-895
18. Hata K, Kubota M, Shimizu M, Moriwaki H, Kuno T et al (2011) C57BL/KsJ-db/db-Apc Mice Exhibit an Increased Incidence of Intestinal Neoplasms. Int J Mol Sci 12(11):8133-8145
19. Sikalidis AK, Fitch MD, Fleming SE (2013) diet induced obesity increases the risk of colonic tumorigenesis in mice. Pathol Oncol Res. doi: 10.1007/s12253-013-9626-0
20. Wolter S, Frank N (1982) Metabolism of 1,2-dimethylhydrazine in isolated perfused rat liver. Chem Biol Interact 42(3):335-344
21. Bird RP (1987) Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 37(2):147-151
22. Lacy ER, Kuwayama H, Cowart KS, King JS, Deutz AH, Sistrunk S (1991) A rapid, accurate, immunohistochemical method to label proliferating cells in the digestive tract. A comparison with tritiated thymidine. Gastroenterology 100(1):259-262
23. Park CM, Reid PE, Walker DC, MacPherson BR (1987) A simple, practical 'swiss roll' method of preparing tissues for paraffin or methacrylate embedding. J Microsc 145(1):115-120
24. Chaudhary M, Mandir N, Fitzgerald AJ, Howard JK, Lord GM et al (2000) Starvation, leptin and epithelial cell proliferation in the gastrointestinal tract of the mouse. Digestion 61(4):223-229
25. Meier U, Gressner AM (2004) Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 50(9):1511-1525
26. Kuate D, Etoundi BC, Azantsa BK, Kengne AP, Ngondi JL, Oben JE (2010) The use of LeptiCore in reducing fat gain and managing weight loss in patients with metabolic syndrome. Lipids Health Dis 9:20
27. Procaccini C, Jirillo E, Matarese G (2012) Leptin as an immunomodulator. Mol Aspects Med 33(1):35-45
28. Härle P, Straub RH (2006) Leptin is a link between adipose tissue and inflammation. Ann NY Acad Sci 1069:454-462
29. La Cava A, Alviggi C, Matarese G (2003) Unraveling the multiple roles of leptin in inflammation and autoimmunity. J Mol Med (Berl) 82(1):4-11
30. Zhou Z, Neupane M, Zhou HR, Wu D, Chang CC, et al. (2012) Leptin differentially regulate STAT3 activation in ob/ob mouse adipose mesenchymal stem cells. Nutr Metab (Lond) 9(1):109
31. Mykoniatis A, Anton PM, Wlk M, Wang CC, Ungsunan L et al (2003) Leptin mediates Clostridium difficile toxin A-induced enteritis in mice. Gastroenterology 124(3):683-691
32. Busso N, So A, Chobaz-Peclat V, Morard C, Martinez-Soria E et al (2002) Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol 168(2):875-882
33. Siegmund B, Lehr HA, Fantuzzi G (2002) Leptin: a pivotal mediator of intestinal inflammation in mice. Gastroenterology 122(7):2011-2025
34. Mackey-Lawrence NM, Petri WA Jr (2012) Leptin and mucosal immunity. Mucosal Immunol 5(5):472-479
35. Mantovani A (2010) Molecular pathways linking inflammation and cancer. Curr Mol Med 10(4):369-373
36. Germano G, Allavena P, Mantovani A (2008) Cytokines as a key component of cancer-related inflammation. Cytokine 43(3):374-379
37. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW et al (2004) IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118(30):285-296
38. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S et al (2004) NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431(7007):461-466
39. Somasundar P, Riggs D, Jackson B, Vona-Davis L, McFadden DW (2003) Leptin stimulates esophageal adenocarcinoma growth by nonapoptotic mechanisms. Am J Surg 186(5):575-578
40. Watanabe N, Takai K, Imai K, Shimizu M, Naiki T et al (2011) Increased levels of serum leptin are a risk factor for the recurrence of stage I/II hepatocellular carcinoma after curative treatment. J Clin Biochem Nutr 49(3):153-158
41. Drew JE (2012) Molecular mechanisms linking adipokines to obesity-related colon cancer: focus on leptin. Proc Nutr Soc 71(1):175-180
42. Hardwick JC, Van Den Brink GR, Offerhaus GJ, Van Deventer SJ, Peppelenbosch MP (2001) Leptin is a growth factor for colonic epithelial cells. Gastroenterology 121(1):79-90
43. Padidar S, Farguharson AJ, Williams LM, Kearney R, Arthur JR, Drew JE (2012) High-fat diet alters gene expression in the liver and colon: links to increased development of aberrant crypt foci. Dig Dis Sci 57(7):1866-1874
44. Hoda MR, Theil G, Mohammed N, Fischer K, Fornara P (2012) The adipocyte-derived hormone leptin has proliferative actions on androgen-resistant prostate cancer cells linking obesity to advanced stages of prostate cancer. J Oncol 2012:280386
45. Nachat-Kappes R, Pinel A, Combe K, Lamas B, Farges MC et al (2012) Effects of enriched environment on COX-2, leptin and eicosanoids in a mouse model of breast cancer. PLoS One 7(12):e51525
46. Hu X, Juneja SC, Maihle NJ, Cleary MP (2002) Leptin-a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 94(22):1704-1711
47. Jaffe T, Schwartz B (2008) Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal-transduction pathways. Int J Cancer 123(11):2543-2556
48. Iversen PO, Drevon CA, Reselnd JE (2002) Prevention of leptin binding to its receptor suppresses rat leukemic cell growth by inhibiting angiogenesis. Blood 100(12):4123-4128
49. Hirose Y, Hata K, Kuno T, Yoshida K, Sakata K et al (2004) Enhancement of development of azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice. Carcinogenesis 25(5):821-825
50. Aparicio T, Guilmeau S, Goiot H, Tsocas A, Laigneau JP et al (2004) Leptin reduces the development of the initial precancerous lesions induced by azoxymethane in the rat colonic mucosa. Gastroenterology 126(2):499-510
51. Sikalidis AK, Varamini B (2011) Roles of hormones and signaling molecules in describing the relationship between obesity and colon cancer. Pathol Oncol Res 17(4):785-790
52. Franco A, Sikalidis AK, Solis Herruzo JA (2005) Colorectal cancer: influence of diet and lifestyle factors. Rev Esp Enferm Dig 97(6):432-448